GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Net Margin %

Argos Therapeutics (FRA:77AA) Net Margin % : -400.94% (As of Sep. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Argos Therapeutics's Net Income for the three months ended in Sep. 2018 was €-4.29 Mil. Argos Therapeutics's Revenue for the three months ended in Sep. 2018 was €1.07 Mil. Therefore, Argos Therapeutics's net margin for the quarter that ended in Sep. 2018 was -400.94%.

The historical rank and industry rank for Argos Therapeutics's Net Margin % or its related term are showing as below:


FRA:77AA's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -150.095
* Ranked among companies with meaningful Net Margin % only.

Argos Therapeutics Net Margin % Historical Data

The historical data trend for Argos Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Net Margin % Chart

Argos Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Margin %
Get a 7-Day Free Trial Premium Member Only -540.99 -2,700.25 -14,423.53 -5,610.60 -2,136.32

Argos Therapeutics Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11,565.91 -113.31 -35.58 -12,056.52 -400.94

Competitive Comparison of Argos Therapeutics's Net Margin %

For the Biotechnology subindustry, Argos Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argos Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argos Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Argos Therapeutics's Net Margin % falls into.



Argos Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Argos Therapeutics's Net Margin for the fiscal year that ended in Dec. 2017 is calculated as

Net Margin=Net Income (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-34.288/1.605
=-2,136.32 %

Argos Therapeutics's Net Margin for the quarter that ended in Sep. 2018 is calculated as

Net Margin=Net Income (Q: Sep. 2018 )/Revenue (Q: Sep. 2018 )
=-4.286/1.069
=-400.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argos Therapeutics  (FRA:77AA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Argos Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Argos Therapeutics (FRA:77AA) Business Description

Traded in Other Exchanges
N/A
Address
4233 Technology Drive, Durham, NC, USA, 27704
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines